Skip to content

VITAL: a trial looking at which general anaesthesia technique is better for patient recovery following major non-cardiac surgery

Volatile vs Total intravenous Anaesthesia for major non-cardiac surgery: A pragmatic randomised triaL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN62903453
Enrollment
2500
Registered
2021-09-29
Start date
2022-01-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total intravenous anaesthesia (TIVA) compared to inhalational volatile-based anaesthesia Surgery

Interventions

VITAL is a multi-centre pragmatic efficient randomised controlled trial with health economic analysis. A 6-month internal pilot phase will seamlessly run into the main trial, on the condition that the

Sponsors

University of Warwick
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age >=50 years 2. Elective major non-cardiac surgery under general anaesthesia (as per PQIP inclusion criteria) 3. Written informed consent for trial participation

Exclusion criteria

Exclusion criteria: 1. Known contraindication to either TIVA or inhalational anaesthesia 2. Clinician refusal 3. Procedures where the participant is not expected to survive for 30 days 4. Previous participation in VITAL trial 5. Patient unable to give informed consent or complete questionnaires

Design outcomes

Primary

MeasureTime frame
Days alive and at home at 30 days (DAH30) measured using patient records

Secondary

MeasureTime frame
1. Days alive and at home at 90 days (DAH90) measured using patient records 2. 30-Day and 90-Day and six-month mortality measured using patient records 3. Quality of recovery after anaesthesia (QoR-15) day 3 post-op 4. Patient satisfaction with anaesthesia (Bauer questionnaire) day 1 post-op. 5. Awareness under anaesthesia measured using the Brice questionnaire day 3 and day 30 post-op.

Countries

United Kingdom

Contacts

Public ContactClaire Jacques
VITAL@warwick.ac.uk+44 (0)2476 522566

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 14, 2026